Investor Relations
- For Shareholders and Investors -

IR Topics

Santen Announces Financial Result for the First Quarter ended June 30, 2010 (Aug 3, 2010)
Notice on the Exercise Price of Stock Options (Stock Acquisition Rights) (Jul 6, 2010)
Notice on the Allotment of Stock Options (Stock Acquisition Rights) (Jun 23, 2010)
Banyu and Santen Launch COSOPT® Combination Ophthalmic Solution: Glaucoma and Ocular Hypertension Drug (Jun 11, 2010)
Renewal of the Countermeasures to Large-Scale Purchases of the Corporation's Shares (Takeover Defense Measures) (May 11, 2010)

An overview of Santen's financial results for the previous five years.

Financial Summary

Past annual reports and data books.

Financial Documents

Schedules for major investor relations events, and presentation materials.

IR Events

Information on Santen shares, shareholders and convertible bonds.

Stock Information

Investor relations contact and submission forms.

IR Contact

Frequently asked questions and answers for shareholders and investors.

FAQ



	Research & Development

	Share Price 20-minute delayed share price and charts. Provided by Nomura Securities Co.,Ltd.

	Download Adobe® Reader® to view PDF files.